Ivacaftor: a review of its use in patients with cystic fibrosis.

Ivacaftor: a review of its use in patients with cystic fibrosis.

Item
http://www.wikidata.org/entity/Q38136994
Constrained bithiazoles: small molecule correctors of defective ΔF508-CFTR protein trafficking.ΔF508-CFTR correctors: synthesis and evaluation of thiazole-tethered imidazolones, oxazoles, oxadiazoles, and thiadiazoles.F508del-cystic fibrosis transmembrane regulator correctors for treatment of cystic fibrosis: a patent review.The Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy.Efficacy and adverse effects of drugs used to treat adult cystic fibrosis.Validation of ion channel targets.Low free drug concentration prevents inhibition of F508del CFTR functional expression by the potentiator VX-770 (ivacaftor).Lumacaftor/Ivacaftor: A Review in Cystic Fibrosis.Can Cystic Fibrosis Patients Finally Catch a Breath With Lumacaftor/Ivacaftor?Medical and Surgical Advancements in the Management of Cystic Fibrosis Chronic Rhinosinusitis.Outcome evaluation of a pharmacy-based therapy management program for patients with cystic fibrosis.
P2860

Ivacaftor: a review of its use in patients with cystic fibrosis.

Item
http://www.wikidata.org/entity/Q38136994
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Ivacaftor: a review of its use in patients with cystic fibrosis.
@en
type
label
Ivacaftor: a review of its use in patients with cystic fibrosis.
@en
prefLabel
Ivacaftor: a review of its use in patients with cystic fibrosis.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921
P356
P1433
P1476
Ivacaftor: a review of its use in patients with cystic fibrosis.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921